4//SEC Filing
LASANTA PEDRO J 4
Accession 0001654954-23-002543
CIK 0001304161other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:23 PM ET
Size
13.1 KB
Accession
0001654954-23-002543
Insider Transaction Report
Form 4
LASANTA PEDRO J
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option
2023-03-06−8,325→ 16,675 totalExercise: $0.99Exp: 2026-12-09→ Common Stock (8,325 underlying) - Exercise/Conversion
Common Stock
2023-03-06$0.99/sh+8,325$8,242→ 126,355 total - Exercise/Conversion
Stock Option
2023-03-06−100,000→ 0 totalExercise: $0.88Exp: 2024-10-04→ Common Stock (100,000 underlying) - Tax Payment
Common Stock
2023-03-06$1.15/sh−76,522$88,000→ 118,030 total - Exercise/Conversion
Common Stock
2023-03-06$0.88/sh+100,000$88,000→ 194,552 total - Tax Payment
Common Stock
2023-03-06$1.15/sh−7,167$8,242→ 119,188 total
Footnotes (3)
- [F1]Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
- [F2]The stock option vested in three equal annual installments beginning on October 4, 2020.
- [F3]On December 9, 2021, the reporting person was granted a stock option to purchase 25,000 shares, which stock option vests in three equal installments beginning on December 9, 2022.
Documents
Issuer
Pharma-Bio Serv, Inc.
CIK 0001304161
Entity typeother
Related Parties
1- filerCIK 0001418477
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:23 PM ET
- Size
- 13.1 KB